[1]
“Patient-Reported Outcomes from Two Randomized, Double-Blind, Vehicle Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)”, J of Skin, vol. 2, no. S1, p. S41, Feb. 2018, doi: 10.25251/skin.2.supp.41.